Different Lipid Emulsions in Acute Lung Injury Patients
Phase 4
Terminated
- Conditions
- Parenteral Nutrition
- Interventions
- Drug: Lipofundin N 20%Drug: Lipoplus 20%
- Registration Number
- NCT01814956
- Lead Sponsor
- B. Braun Melsungen AG
- Brief Summary
Aim is to investigate the influence of an early supply of parenteral nutrition including a fish oil containing lipid emulsion on the course of acute lung injury in the intensive care unit. In comparison, a standard parenteral nutrition with a soybean oil based emulsion will be used. Data obtained in this trial may provide evidence for a beneficial effect of fish oil derived omega-3 fatty acids in parenteral nutrition regarding their influence on acute lung injury.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 1
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 2 Lipofundin N 20% i.v. lipid emulsion for parenteral nutrition 1 Lipoplus 20% i.v. lipid emulsion for parenteral nutrition
- Primary Outcome Measures
Name Time Method change in blood oxygenation (PaO2/FiO2ratio) change day 1 to day 6
- Secondary Outcome Measures
Name Time Method Triglycerides day 1 to day 16 Sequential Organ Failure Assessment day 1 to day 28
Trial Locations
- Locations (1)
University Clinic Giessen
🇩🇪Giessen, Germany